Welcome to the international HTA database

Showing [16409 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	NIHR Health Services and Delivery Research programme	The dynamics of quality: a national panel study of evidence-based standards
2015	Health Quality Ontario (HQO)	Mitral valve clip for treatment of mitral regurgitation: an evidence-based analysis
2015	Adelaide Health Technology Assessment (AHTA)	Endovascular clot retrieval with thrombolysis for ischaemic stroke
2015	National Institute for Health and Care Excellence (NICE)	Omalizumab for previously treated chronic spontaneous urticaria. NICE technology appraisal guidance 339
2015	National Institute for Health and Care Excellence (NICE)	VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions. NICE diagnostics guidance 19
2015	NIHR Health Services and Delivery Research programme	A national study of practice patterns in UK renal units in the use of dialysis and conservative kidney management to treat people aged 75 years and over with chronic kidney failure
2015	Adelaide Health Technology Assessment (AHTA)	Ultra-filtration for patients with decompensated heart failure
2015	National Institute for Health and Care Excellence (NICE)	Ustekinumab for treating active psoriatic arthritis. NICE technology appraisal guidance 340
2015	National Institute for Health and Care Excellence (NICE)	Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). NICE diagnostics guidance 18
2015	NIHR Health Services and Delivery Research programme	Using clinical practice variations as a method for commissioners and clinicians to identify and prioritise opportunities for disinvestment in health care: a cross-sectional study, systematic reviews and qualitative study
2015	Adelaide Health Technology Assessment (AHTA)	Blood and stool biomarker testing for colorectal cancer screening
2015	National Institute for Health and Care Excellence (NICE)	Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. NICE technology appraisal guidance 341
2015	NIHR Health Services and Delivery Research programme	The delivery of chemotherapy at home: an evidence synthesis
2015	NIHR Public Health Research (PHR) programme	The impact on health inequalities of approaches to community engagement in the New Deal for Communities regeneration initiative: a mixed-methods evaluation
2015	Adelaide Health Technology Assessment (AHTA)	Pressurised intraperitoneal aerosol chemotherapy
2015	National Institute for Health and Care Excellence (NICE)	Vedolizumab for treating moderately to severely active ulcerative colitis. NICE technology appraisal guidance 342
2015	NIHR Health Services and Delivery Research programme	The management of individuals with enduring moderate to severe mental health needs: a participatory evaluation of client journeys and the interface of mental health services with the criminal justice system in Cornwall
2015	Adelaide Health Technology Assessment (AHTA)	High-frequency spinal cord stimulation and dorsal root ganglion stimulation for chronic pain
2015	National Institute for Health and Care Excellence (NICE)	Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia. NICE technology appraisal guidance 343
2015	NIHR Health Services and Delivery Research programme	Do higher primary care practice performance scores predict lower rates of emergency admissions for persons with serious mental illness? An analysis of secondary panel data
2015	Adelaide Health Technology Assessment (AHTA)	Leadless Pacemaker
2015	National Institute for Health and Care Excellence (NICE)	Naloxegol for treating opioid-induced constipation. NICE technology appraisal guidance 345
2015	NIHR Health Services and Delivery Research programme	Service user engagement and health service reconfiguration: a rapid evidence synthesis
2015	NIHR Health Technology Assessment programme	Double-blind randomised controlled trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in the treatment of faecal incontinence: CONtrol of Faecal Incontinence using Distal NeuromodulaTion (the CONFIDeNT trial)
2015	Adelaide Health Technology Assessment (AHTA)	Circulating tumour DNA assays
2015	National Institute for Health and Care Excellence (NICE)	Aflibercept for treating diabetic macular oedema. NICE technology appraisal guidance 346
2015	NIHR Health Services and Delivery Research programme	Towards a framework for enhancing procurement and supply chain management practice in the NHS: lessons for managers and clinicians from a synthesis of the theoretical and empirical literature
2015	NIHR Health Services and Delivery Research programme	Ensuring comparisons of health-care providers are fair: development and validation of risk prediction models for critically ill patients
2015	National Institute for Health and Care Excellence (NICE)	Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer. NICE technology appraisal guidance 347
2015	NIHR Health Services and Delivery Research programme	Knowledge exchange in health-care commissioning: case studies of the use of commercial, not-for-profit and public sector agencies, 2011-14
2015	New Zealand National Health Committee (NHC)	Epidermal growth factor receptor gene mutation analysis testing assessment
2015	National Institute for Health and Care Excellence (NICE)	Everolimus for preventing organ rejection in liver transplantation. NICE technology appraisal guidance 348
2015	New Zealand National Health Committee (NHC)	Percutaneous Left Atrial Appendage Occlusion (LAAO) for the prevention of stroke in non-valvular atrial fibrillation (AF) in the New Zealand health system
2015	National Institute for Health and Care Excellence (NICE)	Secukinumab for treating moderate to severe plaque psoriasis. NICE technology appraisal guidance 350
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Algorithms for the management of massive hemoptysis in the acute care setting
2015	New Zealand National Health Committee (NHC)	Age-related macular degeneration
2015	National Institute for Health and Care Excellence (NICE)	Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of antiplatelet therapy (terminated appraisal). NICE technology appraisal guidance 351
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Nurse practitioner models of preceptorship
2015	New Zealand National Health Committee (NHC)	Haematuria: presentation, diagnostic pathway and alternative diagnostic options
2015	National Institute for Health and Care Excellence (NICE)	Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy. NICE technology appraisal guidance 352
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Oral rehydration therapy for adults with acute infectious gastrointestinal disease
2015	National Institute for Health and Care Excellence (NICE)	Bevacizumab for treating relapsed, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal). NICE technology appraisal guidance 353
2015	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the CLASS trial
2015	Agency for Healthcare Research and Quality (AHRQ)	Systematic review for effectiveness of hyaluronic acid in the treatment of severe degenerative joint disease (DJD) of the knee
2015	National Institute for Health and Care Excellence (NICE)	Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism. NICE technology appraisal guidance 354
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Vaccination against pertussis: aims and strategy
2015	National Institute for Health and Care Excellence (NICE)	Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. NICE technology appraisal guidance 355
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Hospitalist clinics for post-discharge care
2015	Health Council of the Netherlands Gezondheidsraad (GR)	4,4'-Methylenedianiline - Health-based calculated occupational cancer risk values
2015	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab. NICE technology appraisal guidance 357
2015	NIHR Health Technology Assessment programme	Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Pre-operative cardiovascular surgery patient education
2015	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of open mesh repairs in adults presenting with a clinically diagnosed primary unilateral inguinal hernia who are operated in an elective setting: systematic review and economic evaluation
2015	Health Council of the Netherlands Gezondheidsraad (GR)	1,4-Dioxane - re-evaluation of the carcinogenicity and genotoxicity
2015	National Institute for Health and Care Excellence (NICE)	Tolvaptan for treating autosomal dominant polycystic kidney disease. NICE technology appraisal guidance 358
2015	Health Council of the Netherlands Gezondheidsraad (GR)	2,6-Xylidine - re-evaluation of the carcinogenicity and genotoxicity
2015	National Institute for Health and Care Excellence (NICE)	Idelalisib for treating chronic lymphocytic leukaemia. NICE technology appraisal guidance 359
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Methodology for the evaluation of the evidence for the Dutch dietary guidelines 2015 - background document
2015	National Institute for Health and Care Excellence (NICE)	Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal). NICE technology appraisal guidance 362
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Inpatient mental health unit décor
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Shiftwork and health risks: possibilities for prevention
2015	National Institute for Health and Care Excellence (NICE)	Ledipasvir-sofosbuvir for treating chronic hepatitis C. NICE technology appraisal guidance 363
2015	National Institute for Health and Care Excellence (NICE)	Ombitasvir-paritaprevir-ritonavir with or without dasabuvir for treating chronic hepatitis C. NICE technology appraisal guidance 365
2015	Health Information and Quality Authority (HIQA)	Guidance on budget impact analysis of health technologies in Ireland
2015	NIHR Health Technology Assessment programme	Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Locking solutions for central venous catheters
2015	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for advanced melanoma not previously treated with ipilimumab. NICE technology appraisal guidance 366
2015	NIHR Health Services and Delivery Research programme	Tele-First: telephone triage as an alternative to face to face contact in general practice
2015	National Institute for Health and Care Excellence (NICE)	Vortioxetine for treating major depressive episodes. NICE technology appraisal guidance 367
2015	NIHR Health Technology Assessment programme	The relative clinical and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections (STIs): a cluster randomised trial in primary care
2015	NIHR Health Services and Delivery Research programme	Intentional rounding in hospital wards: What works, for whom and in what circumstances?
2015	National Institute for Health and Care Excellence (NICE)	Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears. NICE technology appraisal guidance 369
2015	National Institute for Health and Care Excellence (NICE)	Bortezomib for previously untreated mantle cell lymphoma. NICE technology appraisal guidance 370
2015	NIHR Health Technology Assessment programme	Clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in critical care using multi-pathogen real-time polymerase chain reaction (RT-PCR) technology
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Lonsurf (trifluridine and tipiracil hydrochloride) for metastatic colorectal cancer – third line
2015	National Institute for Health and Care Excellence (NICE)	Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis. NICE technology appraisal guidance 373
2015	NIHR Horizon Scanning Centre (NIHR HSC)	AZD9291 for locally advanced or metastatic, EGFR and T790M mutation positive non-small cell lung cancer – second line
2015	Institute of Health Economics (IHE)	A systematic review of the measurement properties of self-report instruments that assess presenteeism
2015	NIHR Health Technology Assessment programme	The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
2015	NIHR Health Services and Delivery Research programme	The SHAPE project: Supporting adults with High-functioning Autism and asPerger syndromE. Mapping and evaluating specialist autism team service models
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Sodium thiosulfate for prevention of hearing loss in children receiving cisplatin chemotherapy
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ipilimumab (Yervoy) for small cell lung cancer – first line, in combination with etoposide and platinum therapy
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib for metastatic uveal melanoma – first line
2015	NIHR Health Services and Delivery Research programme	Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ibrutinib (Imbruvica) for Waldenström's macroglobulinaemia
2015	NIHR Health Technology Assessment programme	Diagnostic accuracy of the Thessaly test, standardised clinical history and other clinical examination tests (Apley's, McMurray's and joint line tenderness) for meniscal tears in comparison with magnetic resonance imaging diagnosis
2015	NIHR Health Services and Delivery Research programme	The value and cost of different forms of information on oral health status and risk given to patients following a check-up in dental practice
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nimotuzumab for advanced pancreatic cancer – second line
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Public health interventions to reduce the secondary spread of measles
2015	NIHR Health Technology Assessment programme	Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation
2015	NIHR Health Technology Assessment programme	The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation
2015	NIHR Health Technology Assessment programme	The PAndemic INfluenza Triage in the Emergency Department (PAINTED) pilot cohort study
2015	Belgian Health Care Knowledge Centre (KCE)	Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Evofosfamide for locally advanced, unresectable or metastatic pancreatic cancer – first line in combination with gemcitabine
2015	Belgian Health Care Knowledge Centre (KCE)	Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening
2015	HAYES, Inc.	Absorbable perirectal spacer (SpaceOAR System; Augmenix Inc.) during radiation therapy for prostate cancer
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ixekizumab for moderate to severe chronic plaque psoriasis
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-term use of acamprosate calcium for alcoholism: a review of the clinical effectiveness, safety, and guidelines
2015	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of parenting interventions for children with severe attachment problems: a systematic review and meta-analysis
2015	Belgian Health Care Knowledge Centre (KCE)	Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology